Inhalation Therapy Market, Size, Share 2021-2028
Added: (Wed Nov 10 2021)
Pressbox (Press Release) -
Market Overview
The global Inhalation Therapy Nebulizer market size was valued US$ YY billion in 2020 and is estimated to reach US$ YY billion by 2028, growing at a CAGR of YY % during the forecast period (2021-2028).
Inhalation therapy nebulizer is a medical device which converts the drug into mist and delivers it directly to the lungs. The technique of inhalation therapy nebulization is commonly used for the treatment of respiratory diseases including asthma, cystic fibrosis, and COPD. Various devices are used for nebulization. The devices that are rechargeable and electrically powered are most widely used.
Download free sample: https://www.datamintelligence.com/download-sample/inhalation-therapy-nebulizer-market
Market Dynamics
The global inhalation therapy nebulizer market market growth is driven by the growing incidence of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base are among the key factors driving market growth.
The increasing prevalence of of chronic respiratory diseases, is expected to drive the growth in the forecast period
The increasing prevalence of of chronic respiratory diseases, increasing demand for home healthcare devices, and rising geriatric population base are driving the market growth. Nebulizers are respiratory drug delivery devices that transform liquid medications into aerosols (liquid particles in a gas). The drug is converted into a mist that can be directly delivered to the patient's lungs. The rising incidences of chronic respiratory diseases and rapid technological advances are among the key factors driving the usage of nebulizers. The adoption is also increasing, due to the demand for new technologies with higher quality, smaller size, lighter weight, and ease of accessibility, by the patients. Thus, the increasing demand for these devices is driving the growth of the market.
Increase demand for home healthcare devices expected to drive the market growth
Home healthcare devices have been gaining popularity and market share in recent years. Miniaturization of products and technological advancements are boosting the adoption of home healthcare devices. Furthermore, rowing need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays, which is expected to boost the market. Easy availability of compact nebulizers that are ideal for home use and technological innovations in nebulizers to reduce the sound created by them and to improve their functionality are increasing their adoption in-home healthcare. These factors are driving the growth of the market in the forecast period. Side-effects associated with drug inhalation is likely to hinder the market growth However, complications and side-effects associated with drug inhalation, unavailability of a single effective inhaler device and lack of awareness are factors restraining the market.
COVID-19 Impact Analysis
Many of the patients use a home nebulizer for care of their respiratory conditions. It is very important that if a patient with COVID-19 or suspected COVID-19 using a nebulizer at home. Moreover, the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is working with regulatory authorities to get approval for a nebulizer-based inhalation therapy it has designed for use in COVID patients. The inhalation therapy for combating COVID-19 is very effective. These factors are driving the growth of the market in the forecast period.
Segment Analysis
– By Type
• Mesh Nebulizer *
• Pneumatic Nebulizer
• Ultrasonic Nebulizer
• Jet nebulizers
– By Applications
• Asthma *
• COPD
• Cystic fibrosis
• Other
Geographical Analysis
North America region holds the largest market share global Inhalation Therapy Nebulizer market
accounted for the largest market share in 2020. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in time of need for patients suffering from asthma and other airway diseases.
In addition, healthcare cost containment issues, post economic crisis in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided impetus to homecare services, which in turn, created a favorable environment for the growth of the inhalation therapy nebulizer market.
Competitive Landscape
The inhalation therapy nebulizer market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Rossmax International Ltd., OMRON Corporation, Koninklijke Philips N.V., PARI Pharma, BD, Medline Industries, Inc., Briggs Healthcare, GF Health Products, Inc., Vectura Group plc, Beurer GmBH among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the inhalation therapy nebulizer market globally.
Inhalation Therapy Nebulizer Market Key Companies to Watch
Beurer Gmbh
Overview: Beurer GmbH is located in Ulm, Baden-Württemberg, Germany and is part of the Medical Equipment & Supplies Manufacturing Industry. Beurer GmbH has 950 total employees across all of its locations and generates $312.73 million in sales (USD). There are 25 companies in the Beurer GmbH corporate family.
Product Portfolio: Beurer GmbH manufactures blood sugar measuring units, blood pressure instruments, fever thermometers, electric blankets, bathroom and kitchen scales, footbaths and nebulizers, pulse watches, and other products.
View Full Report: https://www.datamintelligence.com/research-report/inhalation-therapy-nebulizer-market
Enquiry Before Buying: https://www.datamintelligence.com/enquiry/inhalation-therapy-nebulizer-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com